Global Sternal Closure Systems Market is expected to reach USD 2,301.16 million by 2025 and is projected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Access Full Report: http://databridgemarketresearch.com/reports/global-sternal-closure-systems-market/

Some of the major players operating in this market are B. Braun Melsungen AG, JACE Medical, LLC, Péters Surgical, KLS Martin Group, A&E Medical Corporation, Acute Innovations LLC, Idear SRL, Kinamed Incorporated, Neuro France Implants, Mani, Inc, JEIL MEDICAL CORPORATION, Waston Medical Corporation, Depuy Synthes, Zimmer Biomet, Dispomedica, Praesidia among others.

Zimmer Biomet:

Zimmer Biomet was established in 1927 and headquartered in Indiana, U.S. Zimmer Biomet is a pioneer in musculoskeletal social insurance. It manufactures, designs and markets orthopedic reconstructive items; biologics, sports drug, extremities, coventry staplers biologics and injury products; bone mending, spine, craniomaxillofacial and thoracic items; dental embeds; and related surgical items. The company serves throurh wide range of business segments like knee, hips, S.E.T, dental and Spine and CMF. The sternal closure products are offered in spine and CMF business segment.

The company majorly operates in three different regions and four different product categories. The three major geographic operating sectors are North America, EMEA (Europe and Middle East and Africa), and Asia Pacific.

Zimmer Inc. has its operations in 24 countries. Some of its subsidiaries include Biologics Research facility (Texas), the Zimmer Spine division (U.S.), and the Zimmer Dental division (U.S.).. Biomet (UK), Biomet Manufacturing CORP (U.S.), Biomet 3i LLC (U.S.), EBI, LLC (U.S.), Biomet Biologics, LLC (U.S.), Biomet Microfixation LLC (U.S.), KIRSCHNER MEDICAL CORP (U.S), Biomet Japan, Inc (Japan), Biomet Europe BV (Netherlands).

BRAUN MELSUNGEN AG

• Braun Melsungen AG was founded in 1839 and headquartered at Melsungen, Germany. The company is engaged in manufacturing and providing healthcare solutions. It operates its business through following segments B. Braun Hospital Care, B. Braun Aesculap, B.Braun Avitum, and B. Braun Out Patient Market. The company offers a wide range of products for cardio thoracic surgery, diabetes care, infection prevention, laproscopic surgery, continence care and urology, extracorporeal blood treatment, infusion therapy and among othersintensive care units, anaesthesia, emergency care, extra corporeal, blood treatments and surgical core procedures for hospitals, surgical centres and other private medical institutes. The sternal closure is offered by B.Braun Aesculp business segment.
• B.Braun Melsungen AG product portfolio comprises of 5000 different products. It has offices and facilities in Africa, Asia Pacific, Europe, North America, South America. B.Braun Melsungen AG and its subsidiaries currently have more than 54,000 employees in more than 60 countries. It has various subsidiaries such as Aesculap (U.S.), B. Braun Medical Inc. (U.S.), B. Braun Medical (India) Pvt. Ltd. (India), B. Braun of America, Inc. (U.S.), Saxonia Medical Gmbh (Germany) among others

Depuy Synthes:

Founded in 1895 and headquartered in Indiana, U.S.Depuy Synthes is involved in designing, manufacturing of orthopedic and neurological devices for healthcare professionals and ambulatory surgery centers. The company offers wide range of  services through hip, knee, and shoulder replacement; trauma devices for internal and external fixation services. Spinal care solution for thoracolumbar, cervical, interbody fusion minimally invasive surgery; and high viscosity spinal cement. The company offers the pain management and invasive surgery and high viscosity spinal cement. The company offers devices for traumatology, neurosurgery, spinal procedures, otolaryngology, joint reconstruction, power tools, and craniomaxillo facial.

The company has strong presence in U.S. Depuy Synthes operates as a subsidiary of Johnson and Johnson.